Protein Stability & Formulation
Addressing Biophysical Challenges from Molecule to Drugs
19 November 2026 ALL TIMES WET (GMT/UTC)
The Protein Stability & Formulation conference focuses on understanding and controlling the biophysical behaviors that underpin successful biologic medicines. Sessions will examine aggregation, colloidal stability, and viscosity in complex formats using tools such as machine learning, molecular dynamics, and predictive case studies across antibodies, nanobodies, and multispecifics. Additional talks highlight innovative formulation and delivery strategies—from minimizing aggregates in inhaled biologics to enabling oral delivery of antibodies and long‑acting enzyme therapies.
Preliminary Agenda

Session Block

BIOPHYSICAL STABILITY AND AGGREGATION

KEYNOTE PRESENTATION: What Have We Learned from a Decade of Research into Polysorbate Degradation?

Photo of Patrick Garidel, PhD, Head, Process, Purification and Pharma Development, Biopharma, Boehringer Ingelheim Pharma GmbH, Germany , Head , Pharmaceutical Dev Biologics , Boehringer Ingelheim Pharma GmbH & Co KG
Patrick Garidel, PhD, Head, Process, Purification and Pharma Development, Biopharma, Boehringer Ingelheim Pharma GmbH, Germany , Head , Pharmaceutical Dev Biologics , Boehringer Ingelheim Pharma GmbH & Co KG
Photo of Giuseppe L. Licari, PhD, Lead Scientist, Computational Structural Biology, Global Drug Product Development—BDC, Merck Serono SA , Lead Scientist, Computational Structural Biology , Global Drug Product Development - BDC , Merck Serono SA
Giuseppe L. Licari, PhD, Lead Scientist, Computational Structural Biology, Global Drug Product Development—BDC, Merck Serono SA , Lead Scientist, Computational Structural Biology , Global Drug Product Development - BDC , Merck Serono SA
Photo of Vito Foderà, PhD, Professor, Biophysics, University of Copenhagen , Professor , Pharmacy , University of Copenhagen
Vito Foderà, PhD, Professor, Biophysics, University of Copenhagen , Professor , Pharmacy , University of Copenhagen
Photo of Marlon Hinner, PhD, Group Leader, Roche , Principal Scientist and Matrix Leader , Roche
Marlon Hinner, PhD, Group Leader, Roche , Principal Scientist and Matrix Leader , Roche
Photo of Eric Lorent, PhD, Principal Scientist, Sanofi , Principal Scientist , Early CMC , Sanofi
Eric Lorent, PhD, Principal Scientist, Sanofi , Principal Scientist , Early CMC , Sanofi
Photo of Goran Miličić, PhD, Senior Expert, Science & Technology, Novartis , Senior Expert, Science & Technology , BX-DP/Technical R&D GDD , Novartis
Goran Miličić, PhD, Senior Expert, Science & Technology, Novartis , Senior Expert, Science & Technology , BX-DP/Technical R&D GDD , Novartis

NOVEL DELIVERY AND FORMULATION STRATEGIES

Molecular Dynamics Analysis toward Understanding Formulation Dependent DSC Behavior of Antibodies

Kota Yamaguchi, Research Scientist, Formulation Research, Injectable Technologies, Chugai Pharmaceutical Co Ltd. , Research Scientist , Formulation Research, Injectable Technologies , Chugai Pharmaceutical Co Ltd

Photo of Maurits F Kleijnen, PhD, Head, Research, Intract Pharma Ltd. , Head , Research , Intract Pharma Ltd
Maurits F Kleijnen, PhD, Head, Research, Intract Pharma Ltd. , Head , Research , Intract Pharma Ltd

Saskia Neubacher, PhD, CSO, R&D, Incircular B.V. , CSO , R&D , Incircular B.V.

Photo of Isabel Waibel, Graduate Student, Biochemical Engineering, ETH Zurich , Doctoral Student , Biochemical Engineering , ETH Zurich
Isabel Waibel, Graduate Student, Biochemical Engineering, ETH Zurich , Doctoral Student , Biochemical Engineering , ETH Zurich

For more details on the conference, please contact:

Mimi Langley
Executive Director, Conferences
Cambridge Healthtech Institute
Email: mlangley@healthtech.com

For sponsorship information, please contact:

Companies A-K
Jason Gerardi
Sr. Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-972-5452
Email: jgerardi@healthtech.com

Companies L-Z
Ashley Parsons
Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-972-1340
Email: ashleyparsons@healthtech.com